Abstract
Monetising the damage inflicted to economy and society is necessary and it is doable. The costing of antimicrobial resistance (AMR) enables clearer policy response and removes haziness in decisions. Costing the AMR facilitates the investment in interventions, needed for implementation of One Health.
DOI: https://doi.org/10.5334/aogh.5355 | Journal eISSN: 2214-9996
Language: English
Page range: 53 - 53
Submitted on: May 22, 2026
Accepted on: May 23, 2026
Published on: Jun 10, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2026 Pushpam Kumar, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.